183
Participants
Start Date
October 31, 2010
Primary Completion Date
September 30, 2011
Study Completion Date
September 30, 2011
NGX-1998
Capsaicin topical liquid to be applied for 5 minutes one time only.
Placebo Liquid
Placebo topical liquid to be applied for 5 minutes one time only.
NeurogesX Investigational Site, Huntsville
NeurogesX Investigational Site, Tucson
NeurogesX Investigational Site, Irvine
NeurogesX Investigational Site, La Jolla
NeurogesX Investigational Site, Napa
NeurogesX Investigational Site, San Francisco
NeurogesX Investigational Site, Santa Monica
NeurogesX Investigational Site, New Port Richey
NeurogesX Investigational Site, North Palm Beach
NeurogesX Investigational Site, Sarasota
NeurogesX Investigational Site, St. Petersburg
NeurogesX Investigational Site, Marietta
NeurogesX Investigational Site, Boise
NeurogesX Investigational Site, Bloomington
NeurogesX Investigational Site, West Des Moines
NeurogesX Investigational Site, Kansas City
NeurogesX Investigational Site, Lexington
NeurogesX Investigational Site, Shreveport
NeurogesX Investigational Site, Hyannis
NeurogesX Investigational Site, Ann Arbor
NeurogesX Investigational Site, Minneapolis
NeurogesX Investigational Site, Hattiesburg
NeurogesX Investigational Site, Albany
NeurogesX Investigational Site, Rochester
NeurogesX Investigational Site, Hickory
NeurogesX Investigational Site, Winston-Salem
NeurogesX Investigational Site, Portland
NeurogesX Investigational Site, Altoona
NeurogesX Investigational Site, San Antonio
NeurogesX Investigational Site, Webster
NeurogesX Investigational Site, Salt Lake City
NeurogesX Investigational Site, Richmond
NeurogesX Investigational Site, Seattle
NeurogesX Investigational Site, Wenatchee
NeurogesX Investigational Site, Madison
Lead Sponsor
NeurogesX
INDUSTRY